KBC GLOBAL LTD Q2 RESULTS
Q-comm audits; modest Q1 for IT firms
Happy Wednesday! Due to recent hygiene lapses by quick commerce, the government has intensified surprise inspections of their warehouses. This and more in today’s ETtech Morning Dispatch.
Infosys, Tech Mahindra among 6 IT stocks that could surprise positively in Q1 results: JM Financial
Stating that Tech Mahindra remains a ‘buy' on turnaround hopes while KPIT Technologies and Tata Technologies are structural bets on auto ER&D theme, domestic brokerage firm JM Financial believes that Q1 results for the IT sector could positively surprise the street.
IT stocks rally up to 4% as an early indicator of Q1 earnings just gave green signals
Indian IT stocks surged following positive results from Accenture, with Persistent Systems leading the gains. Analysts expect a strong demand environment to drive healthy earnings growth.
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
Surprise poll results impact startups' plans, and other top stories this week
In a week charged with political buzz, the BJP government came back to power after a stormy election, but without a full majority that left it dependent on the whims of its alliance partners. Unnerved, the markets went into a tailspin on counting day, with both benchmark indices, Sensex and Nifty50, dropping 8% intraday. They recovered a day later as hopes of a stable government revived.
IRCTC shares drop 5% after Q4 results miss Street expectations
IRCTC's stock witnessed a 5% decline, reaching the day's low of Rs 1,028, following the company's announcement of a consolidated profit after tax (PAT) of Rs 284 crore, which was below expectations, marking a modest increase of 1.8% on a year-on-year (YoY) basis.
- Go To Page 1
TVS Supply Chain Solutions Q4 Results: Firm reports consolidated PAT of Rs 5.38 crore
TVS Supply Chain Solutions Ltd reported a profit after tax of Rs 5.38 crore for the quarter January-March 2024, with total income growing to Rs 2,433.06 crore from Rs 2,332.53 crore in the same quarter last year, but facing a consolidated net loss of Rs 90.49 crore for the year ending March 31, 2024.
JP Morgan maintains overweight rating on LIC post Q4 results, sees 29% upside
JP Morgan maintains 'Overweight' rating on LIC post Q4 results, setting target price of Rs 1,340. LIC's market share growth and strong earnings drive stock performance.
Divi’s Laboratories shares rally 5% post Q4 results. Should you buy, sell or hold?
Divi’s Laboratories saw a 5% surge in its shares on the BSE during Monday's trading session, reaching a new 52-week high of Rs 4,335. This rise came as brokerages such as Motilal Oswal and InCred expressed bullish sentiment towards the stock, following the company's impressive performance in Q4, where it reported a 68% year-on-year increase in profits, reaching Rs 538 crore.
Senco Gold Q4 Results: PAT rises 24% YoY to Rs 32 crore; revenue jumps 40%
Senco Gold, a listed jewellery company, experienced a significant boost in its net profit during the fourth quarter of FY24, thanks to the surge in gold prices. The net profit increased by 23.6%, reaching Rs 32.17 crore compared to Rs 26.03 crore in the fourth quarter of FY23.
ITC Q4 Results: Net profit drops marginally to Rs 5,020 crore
Revenue from operations went up by 1.4% at Rs 17,752.87 crore in the period under review. The company said excluding the agri-business (which was severely impacted due to government restrictions in trade of agri-commodities), the company’s gross revenue during the fourth quarter has gone up by 6% y-o-y.
Grasim Q4 Results: Net profit jumps 39% YoY to Rs 1,908 crore; revenue rises 13%
Grasim Q4 Results: The net profit stood at Rs 1,369 crore in the last year quarter. Revenue from operations increased 13% year-on-year to Rs 37,727 crore in the reporting period, compared with Rs 4,873 crore in the corresponding period of previous year.
Sun Pharma net profit jumps 34% YoY to Rs 2,654.6 crore in Q4FY24
Sun Pharma's Q4FY24 net profit rises 34% YoY to Rs 2654.6 crore, driven by increased sales of global specialty products. Interim dividend of Rs. 5 declared for FY24.
Sun Pharma Q4 Results: Profit jumps 34% YoY to Rs 2,654 crore, meets Street estimates
Sun Pharma Q4 Results: The company's revenue rose 10% year-on-year to Rs 11,983 crore in the reporting quarter. It was Rs 10,931 crore a year ago. Its board has approved a final dividend of Rs 5 per share, which will be paid within the prescribed timeline. India formulations sales were Rs 3,707 crore for the fourth quarter, showing growth of 10% over Q4 last year and accounted for 31.4% of total consolidated sales for the quarter.
Zee Entertainment Enterprises shares rise 3% as firm swings back to black in Q4
Zee Entertainment Enterprises experienced a nearly 3% increase in its share price to Rs 144.4 during Tuesday's trading session on the BSE, following the company's announcement of a profit of Rs 13 crore in the March quarter of FY24. This marks a significant turnaround from the loss of Rs 196 crore reported in the same period last year.
Global Health Q4 Results: Net profit rises 25% to Rs 127 crore
For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
Will Nifty hit fresh record high before elections? That depends on these 5 factors
The week may remain lacklustre on the data front as no major economic data releases are scheduled in both the US as well as the Indian market. Indian investors are likely to focus more on the ongoing earnings season as well as stock specific developments. Nifty and Sensex have reached all-time highs driven by US Fed data and expert insights. Key factors that will shape market outlook.
ZEE Entertainment shares rally 5% after Q4 results. Should you buy, sell or hold?
ZEE Share Price: ZEEL swung back to profit in March quarter against loss a year ago. Its total income in the reporting quarter, too, increased 3% YoY to Rs 2,185 core. Goldman Sachs sees partial recovery in revenues as a positive sign.
Vodafone Idea Q4 Results: Net loss widens vs Q3; ARPU rise to Rs 146
Vodafone Idea’s net loss for the fiscal fourth quarter, FY24, widened sequentially to Rs 7,675 crore, dragged by high debt and even as it continued to lose subscribers.
Biocon Q4 Results: Net profit drops 57% to Rs 136 crore
Total revenue grew 1% YoY to Rs 3,966 crore. EBITDA for the quarter declined 16% YoY to Rs 964 crore, representing an EBITDA margin of 24% versus 29% in the same period last year. The gross R&D spends declined 36% YoY to Rs 228 crore in Q4FY24.
GIFT Nifty down 40 points; here's the trading setup for today's session
"We expect this volatility to continue in the near term in the absence of any major positive trigger. Now till Nifty holds below 22000 zones, weakness could be seen towards 21700," said Siddhartha Khemka, Head - Retail Research, Motilal Oswal.
Bank of Baroda Q4 Results: PAT rises 2% YoY to Rs 4,886 crore; dividend declared at Rs 7.6/share
Bank of Baroda Q4 Results: The board also recommended a dividend of Rs 7.60 per equity share for FY2023-24
Canara Bank Q4 Results: Profit jumps 18% YoY to Rs 3,757 crore; NII rises 11%
Canara Bank Q4 Results: The company's Board has also recommended a dividend of Rs 16.10 per share, 161% of face value each, for the financial year 2023-24
GIFT Nifty up 5 points; here's the trading setup for today's session
"Although Nifty opens positive, it is witnessing resistance at higher levels, indicating cautiousness among the investors with the progress of both the result season and the Lok Sabha election. We expect this volatile move to continue till the Exit poll. Hence market to remain in a broader range until clarity emerges," said Siddhartha Khemka, Head - Retail Research, Motilal Oswal.
Dr Reddy's Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share
Dr Reddy's Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.
Ambuja Cements Q4 results: Profit up 6% YoY to Rs 532 cr; co approves Rs 2 dividend
Ambuja Cements reported a standalone net profit of 532 crore rupees for the quarter that ended in March 2024, showing a 6% increase compared to the previous year. Revenue from operations in the fourth quarter rose by 12% year-on-year to Rs 4,780 crore. The Board has recommended a dividend of Rs 2 per equity share for the financial year 2023-24, subject to approval of shareholders of the company.
IDFC First Bank shares fall nearly 6% after Q4 results. Should you invest?
In the January-March quarter, IDFC First Bank disclosed an interest income of Rs 8,219.21 crore, a notable increase from Rs 6,424.35 crore reported in the corresponding period of the previous year. This represents a substantial year-on-year growth of 28%.
HCL Tech shares fall 6% after Q4 results. Should you buy, sell or hold?
HCL Technologies shares dropped 6% after reporting Q4FY24 results. Various brokerages offered different perspectives, with targets ranging from Rs 1,300 to Rs 1,700. The company's performance and guidance for FY25 were key points of analysis.
Nestle India shares drop 2% after Q4 results. Buy, sell or hold?
Nestle India's share price fell 2% to Rs 2,511.60 after Q4 results. Standalone net profit rose 27% to Rs 934 crore, revenue increased 9% to Rs 5,268 crore. Brokerages hold mixed views on the stock.
Load More
